GlassScriptPhysician profile
Stephanie Porter
NPI 1366831455
$10,762.97
in general payments reported to CMS, 2019-2025
40 companies · $2,493 in 2025
The $2,493 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $910 · 2022: $1,996 · 2023: $1,991 · 2024: $3,373 · 2025: $2,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,849 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Education: $8.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,848.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Education | $8.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $3,199.28 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $1,077.81 | 2021-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $1,008.07 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $822.32 | 2021-2025 | Mounjaro, Jardiance, Lyumjev |
| Sanofi-Aventis U.S. LLC | $471.17 | 2021-2025 | |
| Corcept Therapeutics | $464.39 | 2023-2025 | Korlym |
| Dexcom, INC. | $448.47 | 2021-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $372.15 | 2021-2023 | Farxiga |
| Xeris Pharmaceuticals, INC. | $309.48 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Insulet Corporation | $304.18 | 2021-2025 | Omnipod |
| Intuitive Surgical, INC. | $278.05 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $250.65 | 2022-2025 | |
| Medtronic, INC. | $207.95 | 2023-2025 | Minimed 780g, Intellis Adaptivestim, Inceptiv |
| Beta Bionics, INC. | $154.84 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Abbvie INC. | $144.83 | 2022-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $123.84 | 2023-2024 | |
| Cequr Corporation | $116.52 | 2022-2024 | Cequr Simplicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.12 | 2022-2024 | Jardiance, Synjardy, Tradjenta |
| Ascensia Diabetes Care US INC. | $111.32 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $98.69 | 2021-2023 | Steglatro, Verquvo, Steglujan |
| Amgen INC. | $74.84 | 2022-2025 | Evenity, Prolia, Tepezza |
| Sequel Med Tech, LLC | $70.89 | 2025 | Twiist |
| Chiesi USA, INC. | $63.36 | 2024 | Mycapssa |
| Alexion Pharmaceuticals, INC. | $53.15 | 2021-2025 | Strensiq |
| Ibsa Pharma INC. | $52.82 | 2022-2023 | Tirosint, Licart |
| Lifescan, INC. | $43.18 | 2022 | |
| Amryt Pharma Holdings LTD | $41.83 | 2022 | |
| Antares Pharma, INC. | $35.60 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Madrigal Pharmaceuticals | $31.70 | 2025 | Rezdiffra |
| Currax Pharmaceuticals LLC | $25.93 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $23.31 | 2025 | |
| Baxter Healthcare | $22.25 | 2025 | Perclot |
| Boston Scientific Corporation | $20.17 | 2021 | |
| Recordati_rare_diseases_inc. | $19.34 | 2021 | |
| Endo Pharmaceuticals INC. | $19.23 | 2022 | |
| Echosens North America, INC. | $18.94 | 2024 | Fibroscan |
| Hologic Sales and Service, LLC | $18.28 | 2023 | Coolseal Generator |
| Ascendis Pharma Endocrinology INC | $16.72 | 2025 | Yorvipath |
| Paratek Pharmaceuticals, INC. | $16.49 | 2025 | Nuzyra |
| Amneal Pharmaceuticals LLC | $14.81 | 2024 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.